Microscopic, bottle-like structures with corks that melt at precisely-controlled temperatures could potentially release drugs inside the body or fragrances onto the skin, according to a recently published study.
Typical drug delivery systems act more like sponges than bottles. For example, drugs are absorbed into polymer particles and then allowed to diffuse out over time. The researchers hope that the new system may allow for greater control of drug delivery. Cargo would stay inside the hollow polymer particle when plugged with a solid cork. When the cork is melted by body heat, the drugs would quickly flow out of the particle bottle.
“It’s just like when you open wine, you remove the cork,” said Younan Xia, a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Xia also holds joint appointments in School of Chemistry and Biochemistry and the School of Chemical and Biomolecular Engineering at Georgia Tech.
The melting corks are made of fatty acids, derived from natural oils and fats. The length of the hydrocarbon chains on these molecules can be made longer or shorter to increase or decrease, respectively, the temperature at which they melt. This way, the fragrances in deodorants, for example, would be released only when a person gets hot and sweaty.
The new system for temperature-regulated release was detailed in a recent online edition of the journal Angewandte Chemie International Edition. The research was sponsored by the National Cancer Institute, a National Institutes of Health Director’s Pioneer Award, and startup funds from Georgia Tech. Funds were also provided by the Korea Science and Engineering Foundation (KOSEF) and the Korean Ministry of Education and Science.
Drug delivery systems have also been designed to release their cargoes in response to pH change, ultrasound, mechanical signals and electric or magnetic fields. Xia’s system is the first bottle-and-cork design, but it isn’t the first to release drugs in response to temperature. His system, however, has several advantages over other temperature-regulated delivery systems, such as quick and efficient loading of small molecules, macromolecules and even nanoparticles up to 100 nanometers in size. Other temperature-based systems can release their cargoes early. In Xia’s system, the contents are bottled up until the body hits the desired temperature and then they are quickly released.
“It’s like bottled water,” Xia said. “When you are thirsty, you can just drink it.”
The melting corks are made from a group of phase-changing materials — fatty acids or fatty alcohols — that change from solid to liquid when heated to specific melting points. As a proof of principle for the temperature-sensitive delivery system works, in the new study Xia’s lab loaded fluorescent dye into the hollow polymer particles. The holes were then corked with solid 1-tetradecanol, a fatty alcohol. After washing away any dye that might be stuck to the outer surfaces of the bottles, a fluorescent micrograph showed that all of the dye was completely bottled up.
The bottles were then heated to 25 and 37 degrees Celsius — just below the corks’ melting point — but no dye escaped, even after 4 days and vigorous washing in a buffer solution. This performance is better than other delivery systems, Xia said, which typically release some of the drug prematurely.
When bottles were heated to 39 degrees Celsius, the melting point of 1-tetradecanol, the corks melted and the dye was instantly released.
“You can bottle everything and then you put a stopper on top. Whenever you need it, just unplug it and things will come out quickly,” said Xia, who is a Georgia Research Alliance Eminent Scholar in Nanomedicine.
The corks tested in the study are expected to pose no harm once inside or on the human body. 1-tetradecanol and lauric acid, a fatty acid that has also been test as a cork, have very low toxicity in small doses, Xia said, because they are derived from natural fats and oils. These same fats are often used as ingredients for food and pharmaceuticals.
Xia said that hydrophobic drugs, such as the majority of anticancer treatments, could be easily loaded into the hollow particles for delivery inside the body. Future studies will examine this possibility in more detail in animal models. Hydrophilic drugs could also be delivered with this system, but the surface of the bottle would need to be modified.
The Latest Bing News on:
Drug delivery system
- Biocon signs deal with Medix for distribution and commercialisation of weight loss drug in Mexicoon May 12, 2024 at 10:48 pm
The total addressable market opportunity of Liraglutide for obesity indication in Mexico is approximately US $37 million as per the IQVIA MAT Q4 2023.
- Embedding Sustainability in Drug Delivery through Industry Consensus at CPHI NAon May 10, 2024 at 12:45 pm
At CPHI NA, Rachel Harris, AstraZeneca, spoke on her work at BioPhorum to enable industry consensus and action for sustainability with drug delivery devices.
- Transdermal Drug Delivery Systems Market Strategies: How to Stay Competitive in 2024-2032on May 9, 2024 at 6:07 pm
Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period ...
- Nature's Blueprint: Biodegradable Materials in Engineered Drug Delivery Systemson May 7, 2024 at 1:09 am
In the field of pharmaceutical sciences, drug is delivered either by conventional mode or controlled/ targeted mode to treat the disease. In controlled drug delivery, drug concentration is maintained ...
- Subcutaneous Drug Delivery Devices Market Future Looks Promising for Market Size as it Takes Offon May 5, 2024 at 2:50 pm
Subcutaneous Drug Delivery Devices Market is valued approximately at USD 9.7 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2020-2027.
- Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drugon May 4, 2024 at 5:00 pm
Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, ...
- Advanced Drug Delivery Market Size to Surpass USD 375.86 Billion by 2033on May 3, 2024 at 8:05 am
Ottawa, May 03, 2024 (GLOBE NEWSWIRE) -- The global advanced drug delivery market size was valued at USD 234.84 billion in 2023 and is estimated to be worth around USD 347.99 billion by 2032, a study ...
- Sustained drug delivery: Advancing long-acting injectables (LAIs) with biodegradable microsphereson May 2, 2024 at 9:02 pm
Long-acting injectables (LAIs) are sustained drug delivery systems specifically designed so that medication is released into the body gradually over an extended period of time. Image Credit: Powder ...
- Drug device maker names operations chief ahead of St. Louis-area expansionon May 2, 2024 at 5:21 am
A manufacturer of drug-delivery devices has named a St. Louis-based operations chief to oversee its global operations as it completes a $100 million expansion of a local facility. A manufacturer of ...
- New Closed-Loop Drug Delivery System Could Improve Chemotherapyon April 24, 2024 at 5:00 pm
When cancer patients undergo chemotherapy, the dose of most drugs is calculated based on the patient’s body surface area. This is estimated by plugging the patient’s height and weight into an equation ...
The Latest Google Headlines on:
Drug delivery system
[google_news title=”” keyword=”Drug delivery system” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Drug delivery
- Vietnam Advanced Dermatology Drug Delivery Devices Market Size, Share, Key Players, Revenue, Demand, and Forecast to 2024 to 2032on May 12, 2024 at 11:33 pm
According to the latest report by Report Ocean, titled this “Vietnam Advanced Dermatology Drug Delivery Devices Market” Report gives evaluation and insights primarily based on authentic consultations ...
- Utahn may be on verge of a significant breakthrough in treating Alzheimer’son May 12, 2024 at 2:00 pm
Still, scientific research takes time and money. With dwindling amounts of both when she came to the University of Utah (Alzheimer’s research isn’t her only iron in the fire), Cross confesses she was ...
- OSU researchers develop device to improve delivery of gene therapy for lung diseaseon May 11, 2024 at 8:28 pm
PORTLAND, Ore. (KTVZ) – Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic ...
- Q&A with the DA: Sentencing in drug crimeson May 11, 2024 at 4:30 am
The information in this special series is for educational purposes only and is not intended to address any particular case, nor should any articles be taken as legal ...
- Embedding Sustainability in Drug Delivery through Industry Consensus at CPHI NAon May 10, 2024 at 12:45 pm
At CPHI NA, Rachel Harris, AstraZeneca, spoke on her work at BioPhorum to enable industry consensus and action for sustainability with drug delivery devices.
- Transdermal Drug Delivery Systems Market Strategies: How to Stay Competitive in 2024-2032on May 9, 2024 at 6:07 pm
Global Transdermal Drug Delivery Systems Market is valued approximately at USD 59.16 billion in 2022 and is anticipated to grow with a growth rate of more than 11.90% over the forecast period ...
- Ocular Drug Delivery Market Updates 2024 : Rise in…on May 9, 2024 at 3:30 am
According to a new report published by Allied Market Research, titled, “Ocular Drug Delivery Market,” The ocular drug delivery market size was valued at $67.7 billion in 2022, and is estimated to ...
- John Patton, Leiter des Kindeva Drug Delivery’s Scientific Advisory Board, zum Gewinner des Charles G. Thiel Preises der RDD Conference ernannton May 8, 2024 at 4:07 pm
John Patton, Leiter des Kindeva Drug Delivery’s Scientific Advisory Board, zum Gewinner des Charles G. Thiel Preises der RDD Conference ernannt ...
- Injectable drug delivery market poised for 8.6% CAGR growth until 2029on May 7, 2024 at 10:26 pm
The market’s revenue is set to reach $1139.4b within the forecast period. Revenue for the global injectable drug delivery market is set to grow by $1139.4b at a compound annual growth rate (CAGR) of 8 ...
- Injectable Drug Delivery Market Worth $1139.4 billion | MarketsandMarkets™on May 6, 2024 at 7:31 am
Injectable Drug Delivery Market in terms of revenue was estimated to be worth $754.5 billion in 2024 and is poised to reach $1139.4 billion by 2029, growing at a CAGR of 8.6% from 2024 to 2029 ...
The Latest Google Headlines on:
Drug delivery
[google_news title=”” keyword=”drug delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]